GANDOLFI, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 588
EU - Europa 43
AS - Asia 12
AF - Africa 4
SA - Sud America 1
Totale 648
Nazione #
US - Stati Uniti d'America 587
FR - Francia 13
DE - Germania 9
VN - Vietnam 8
IE - Irlanda 5
GB - Regno Unito 4
SE - Svezia 4
IT - Italia 3
AE - Emirati Arabi Uniti 2
FI - Finlandia 2
ZA - Sudafrica 2
AT - Austria 1
CA - Canada 1
CI - Costa d'Avorio 1
CL - Cile 1
CN - Cina 1
NG - Nigeria 1
NL - Olanda 1
PL - Polonia 1
SG - Singapore 1
Totale 648
Città #
Ashburn 361
Santa Cruz 26
Fairfield 25
Seattle 17
Woodbridge 15
Buffalo 14
Cambridge 8
Houston 8
Boardman 6
Dublin 5
Wilmington 5
Bremen 4
Dong Ket 4
Stockholm 4
Ann Arbor 3
Chicago 3
Redmond 3
San Diego 3
Southend 3
Clearwater 2
Dallas 2
Helsinki 2
Jacksonville 2
Los Angeles 2
Mountain View 2
Muizenberg 2
Palo Alto 2
Paris 2
Provo 2
Abidjan 1
Basking Ridge 1
Beijing 1
Brandenburg 1
Council Bluffs 1
Groningen 1
Henderson 1
Lagos 1
Liberty Lake 1
Milpitas 1
New York 1
Ottawa 1
Pasadena 1
Phoenix 1
Pisa 1
Prato 1
Rome 1
San Jose 1
South Bend 1
Tampa 1
Warsaw 1
Totale 558
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years, file e1dcb335-285c-7715-e053-1705fe0a6cc9 273
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study, file e1dcb335-6035-7715-e053-1705fe0a6cc9 222
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience, file e1dcb333-6fd6-7715-e053-1705fe0a6cc9 89
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results, file e1dcb334-f6ec-7715-e053-1705fe0a6cc9 80
Totale 664
Categoria #
all - tutte 1.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 4 6 4 7 6 2 2
2020/202173 7 7 4 1 2 7 4 12 8 7 8 6
2021/202295 7 11 2 3 11 2 4 4 4 0 34 13
2022/202374 1 2 29 14 3 6 2 1 6 0 10 0
2023/2024391 4 2 3 6 2 7 325 38 3 1 0 0
Totale 664